Term Gallery logo

Significados de ftld em inglês

espanhol
degeneracion lobular frontotemporal
catalão
degeneració lobar frontotemporal

Group of disorders.

Termos relacionados
degeneracion lobular frontotemporal
Sinônimos
Examples for "frontotemporal lobar degeneration"
Examples for "frontotemporal lobar degeneration"
1
Methods: Electronic databases were searched using terms related to frontotemporal lobar degeneration and movement disorders.
Pubmed
2
Mutations in the gene encoding PGRN give rise to shortage of PGRN and cause familial frontotemporal lobar degeneration.
Pubmed
3
Summary: This represents the first systematic review and meta-analysis of the occurrence of movement disorder phenomenology in genetic frontotemporal lobar degeneration.
Pubmed
4
These findings further highlight that plasma PGRN levels may not accurately predict clinical features or response to future frontotemporal lobar degeneration therapies.
Pubmed
5
Mutations in various RBPs cause several diseases of the central nervous system, including frontotemporal lobar degeneration, amyotrophic lateral sclerosis and fragile X syndrome.
Pubmed
Uso de ftld em inglês
1
Objective: To compare demographic characteristics of patients in the 3 FTLD subgroups.
Pubmed
2
Results: The frontotemporal dementia subgroup represented approximately half of all FTLD diagnoses.
Pubmed
3
The publication of consensus criteria for FTLD, however, prompted systematic studies.
Pubmed
4
FTLD is a more common form of dementia than previously recognized.
Pubmed
5
Recent findings have shown that this domain is hypomethylated in patients with FTLD-FUS.
Pubmed
6
In most ALS and FTLD cases, the predominant pathological species are RNA-binding proteins.
Pubmed
7
Extrapyramidal motor symptoms were more likely to be present in FTLD.
Pubmed
8
However, no increases were observed in any of the five factor scores in FTLD.
Pubmed
9
Autopsy in three family members showed a consistent and unique subtype of FTLD-TDP pathology.
Pubmed
10
Hence, ALS and FTLD converge in pathogenic pathways disrupting the regulation of RNA processing.
Pubmed
11
The sex and age-at-onset differences suggest that there may be biological differences among FTLD subgroups.
Pubmed
12
There was no significant FTLD or motor neuron disease.
Pubmed
13
This suggests additional variants and genes that remain to be identified as risk factors for FTLD.
Pubmed
14
These findings highlight this process as a novel and promising therapeutic target for ALS and FTLD.
Pubmed
15
Moreover, 19 proteins were selectively decreased in FTLD-U.
Pubmed
16
The present review aims to underscore the necessity of further elucidation of PGRN biology in FTLD-related neurodegeneration.
Pubmed